Obesity is associated with a range of health outcomes that are of clinical and public health
significance, including cancer. Herein, we summarize epidemiologic and preclinical …

Learning Objectives Describe the influences of different types of glucose‐lowering
medications on therapeutic outcomes of cancer patients who received standard anticancer …

Aims/hypothesis The results from prospective cohort studies of prediabetes (impaired fasting
glucose and/or impaired glucose tolerance) and risk of cancer are controversial. We …

Objective To derive and validate a set of clinical risk prediction algorithm to estimate the 10-
year risk of 11 common cancers. Design Prospective open cohort study using routinely …

Both diabetes mellitus and cancer are prevalent diseases worldwide. It is evident that there
is a substantial increase in cancer incidence in diabetic patients. Epidemiologic studies …

Background The role of metabolic syndrome (MetS) in prostate cancer risk is still debated.
We investigated it in a large population-based case–control study. Methods Cases were …

Purpose Diabetes mellitus is associated with a decreased risk of prostate cancer. However,
previous studies examining the associations between diabetes mellitus and prostate cancer …

Background: Recent clinical trials indicated that metformin intake might play a protective role
in the incidence and oncologic outcomes of various cancers. However, its protective effect …

Background Although a previous meta-analysis reported no association between metabolic
syndrome (MetS) and prostate cancer risk, a number of studies suggest that MetS may be …

Background: Prostate cancer is one of the most common types of cancer in the US, and it
has a high mortality rate. Diabetes mellitus is also a dangerous health condition. While some …